Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Formerly an independent developer and manufacturer of specialized cell culture media, sera, growth supplements, and reagents for biomedical research and biopharmaceutical production. Acquired by GE Healthcare in 2011 to expand GE's upstream capabilities in bioprocessing. No clinical pipeline as the company was focused on supplying critical raw materials for life science R&D and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PAA Laboratories.